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Background: Microvascular obstruction (MVO) detected by contrast-enhanced cardiac magnetic resonance (CE-CMR) is a well-known predictor 
of adverse left ventricular remodeling (aLVR) after reperfused acute myocardial infarction (AMI), while the influence of myocardial haemorrhage 
(MH) on aLVR is still unclear. Aim of the present study was to test the hypothesis that MH can improve the ability to identify patients at risk of aLVR 
beyond MVO.
Methods: Sixty-two AMI patients (88% males, 57±11 years, 64% anterior location) reperfused with primary percutaneous coronary intervention 
were referred for a CE-CMR assessment during index hospitalization and at 4 months. Left ventricular remodeling was defined as the difference 
between acute and 4-month LV end-systolic volume index. MVO and MH were semi-quantitatively estimated using a per-segment basis (presence 
or absence) score on a 16-segment model of the LV. The ability of MVO, MH and other potential predictors, including age, sex, MI location, TIMI flow 
pre- and post-reperfusion, acute LV ejection fraction, MI size (extent of delayed enhancement at CE-CMR), CK-MB peak, pain-to-balloon time, to 
predict aLVR was assessed by linear regression, with univariable and multivariable analysis.
Results: MH and MVO were observed in 24 (39%) and 46 (74%) patients respectively. MH was always associated with MVO and the extent of MVO 
was significantly larger in the MH group (3.9±1.5 vs 2.3±1.2 segments, p<.0001). Compared to patients with MVO only, those with both MH and 
MVO had similar acute end-systolic LV volume index (MVO only:44.2±15.4 vs MVO+MH:48.8±16 ml/m2, p=.77 respectively), MI size (28±7 vs 27.5 
±12 %, p=.99), acute LV ejection fraction (46.7±9.1 vs 45.4±10 %, p=.96). At univariable analysis MVO (F=9.8, r=.36, p=.003), MH (F=10.2, r=.38, 
p=.002), peak CK-MB (F=6.3, r=.30, p=.015), MI size (F=5.3, r=.27, p=.025) were significant predictors of aLVR. In multivariable analysis only MVO 
retained the ability to predict aLVR (F=11.7, r=.41, p=.001).
Conclusion: MH is always associated with MVO and can predict aLVR in univariable analysis but did not show independent predictive value 
beyond MVO.
